Transcranial magnetic stimulation for the treatment of anxiety disorder.
Priscila Aparecida RodriguesAna Luiza ZaninottoIuri Santana NevilleCintya Yukie HayashiAndre Russowsky BrunoniManoel Jacobsen TeixeiraWellingson Silva PaivaPublished in: Neuropsychiatric disease and treatment (2019)
Anxiety is currently one of the main mood changes and can impair the quality of life of the individual when associated with other neurological or psychiatric disorders. Neuromodulation has been highlighted as a form of treatment of several pathologies, including those involving anxiety symptoms. Among the neuromodulatory options with the potential to improve mood changes, we highlight repetitive transcranial magnetic stimulation (rTMS). rTMS is a viable therapeutical option for neuropsychiatric dysfunctions of high prevalence and is important for the understanding of pathological and neuropsychological adaptation processes. Even with this potential, and high relevance of intervention, we observe the scarcity of literature that covers this subject. The objective of this study was to carry out a survey of the current literature, using scientific databases for the last five years. We found 32 studies reporting the effects of rTMS on anxiety, 7 on anxiety disorders and 25 on anxiety symptoms as comorbidities of neurological or psychiatric disorders. This survey suggests the need for further studies using TMS for anxiety in order to seek strategies that minimize these anxiety effects on the quality of life of the victims of this disorder.
Keyphrases
- transcranial magnetic stimulation
- high frequency
- sleep quality
- systematic review
- depressive symptoms
- bipolar disorder
- randomized controlled trial
- emergency department
- physical activity
- risk assessment
- cross sectional
- big data
- machine learning
- human health
- risk factors
- mild cognitive impairment
- intimate partner violence